Shares of vaccine makers fell on reports that President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr., a ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025Reiterate cash runway into mid-2026; Q3 2024 ending ...

Harte Hanks, Inc. , a leading global customer experience company focused on bringing companies closer to customers for over 100 years, today announced financial results for the third quarter ended ...